The c-myb gene encodes a sequence speci®c transactivator that is required for fetal hematopoiesis, but its potential role in other tissues is less clear because of the early fetal demise of mice with targeted deletions of the c-myb gene and incomplete of knowledge about c-myb's expression pattern. In the hematopoietic system, c-Myb protein acts on target genes whose expression is restricted to individual lineages, despite Myb's presence and role in multiple immature lineages. This suggests that c-Myb actions within dierent cell type-speci®c contexts are strongly aected by combinatorial interactions. To consider the possibility of similar c-Myb actions could extend into non-hematopoietic systems in other cell and tissue compartments, we characterized cmyb expression in developing and adult mice using in situ hybridization and correlated this with stage-speci®c dierentiation and mitotic activity. Diverse tissues exhibited strong c-myb expression during development, notably tooth buds, the thyroid primordium, developing trachea and proximal branching airway epithelium, hair follicles, hematopoietic cells, and gastrointestinal crypt epithelial cells. The latter three of these all maintained high expression into adulthood, but with characteristic restriction to immature cell lineages prior to their terminal dierentiation. In all sites, during fetal and adult stages, loss of c-Myb expression correlated strikingly with the initiation of terminal dierentiation, but not the loss of mitotic activity. Based on these data, we hypothesize that c-Myb's function during cellular dierentiation is both an activator of immature gene expression and a suppressor of terminal dierentiation in diverse lineages.
Keywords: in situ hybridization; transcription factor; repression; anti-dierentiation; development; stem cell; embryogenesis Myb transcription factors (c-Myb, a-Myb, b-Myb and the retroviral v-Myb forms) are sequence speci®c DNA-binding proteins that have strong eects on cellular proliferation and gene expression (Introna et al., 1994; Lyon et al., 1994; Thompson and Ramsay, 1995) . Forms of v-Myb in the avian retroviruses AMV and E26 cause acute myelomonocytic and erythroid leukemias in chickens (Klempnauer et al., 1982) and dysregulated expression of c-Myb by viral insertional mutagenesis can cause myeloid leukemia in mice (Mukhopadhyaya and Wol, 1992) . Mouse c-myb gene knockout causes severe multi-lineage anemia and death by fetal day 15 (Mucenski et al., 1991) . Stagespeci®c down-regulation of c-Myb has been shown to be required for dierentiation and cell cycle-exit of immature hematopoietic cells (Cuddihy et al., 1993; Gewirtz et al., 1989) . These and other results have established c-Myb as a non-redundant transcription factor, critical for the generation of erythroid, myeloid, and lymphoid hematopoietic cell types. However, the mechanism by which c-Myb in¯uences cellular proliferation and dierentiation is poorly understood. The simplest hypothesis for c-Myb actions is that it acts on multiple genes through direct positive interactions (Ess et al., 1995; Hsiang et al., 1995; Mizuguchi et al., 1995; Ness et al., 1993; Queva et al., 1992) . In contrast to the multiple hematopoietic lineages aected by the c-Myb knockout, speci®c gene targets of c-Myb action are con®ned to individual hematopoietic cell lineages. This suggest that c-Myb's actions on speci®c gene targets may be the result of its ability to interact with other cell speci®c transcription factors. c-Myb expression has been observed in multiple sites outside of hematopoietic system (Ess et al., 1995; Torelli et al., 1987; Rosenthal et al., 1996; Sitzmann et al., 1996) , but the early lethality of the knockout animal's severe anemia (Mucenski et al., 1991) has prevented clari®cation of its potential signi®cance outside of hematopoiesis. However, its strong role in the hematopoietic system suggests it could play a similarly powerful role in its additional sites of expression. In order to better understand cMyb's in vivo role, we have sought to better understand its expression in multiple tissue sites during in vivo developmental dierentiation.
As shown in Figure 1 , c-myb expression in the developing thymus reveals expression in the earliest detectable day 12 thymic rudiment populated with very immature thymocyte. By day 18 (Figure 1b) , with thymic maturation, c-myb expression is maintained at high level in the cortex, but the earliest detectable thymic medulla, comprised of maturing T-cells shows complete downregulation of c-myb expression. This becomes much more clear in the adult thymus ( Figure  1c) , where the medullary regions are prominent and also entirely negative for c-myb mRNA. (e and f) Bone Marrow, Adult. c-myb is strongly expressed by only a small percentage of blastoid appearing cells, but is absent from cells that exhibited myeloid or erythroid dierentiation. High-powered view, Final magni®cation 10006. E, bright®eld, F, dark®eld. Mouse embryos and tissues were prepared for cryosectioning and subjected to in situ hybridization analysis as previously described (Aronow et al., 1989 (Aronow et al., , 1992 ) using amino-terminal 0.6 kb HindIII ± EcoRI fragments from pRSVmyb (Cuddihy et al., 1993) subcloned into pBluescript SK + (Stratagene) and linearized with HindIII or EcoRI. Sense and antisense transcripts were labeled using a-35 S-UTP. Identical results were obtained using a carboxyl terminal 0.5 kb PstI ± PstI fragment. Sense probes were always negative for any hybridization signal Fetal liver shows prominent expression of c-myb in hematopoietic cell types as early as day 10.5 (not shown) and even more so by day 12 (Figure 1d ). However, mature myeloid cells and megakaryocytes appeared to completely lack c-myb expression at at day 16.5. Consistent with previous Northern blot analyses of c-myb expression (Sheiness and Gardinier, 1984; Thompson et al., 1986) , strong c-myb signal is found in the bone marrow, but it is con®ned to blastoid cells. These bone marrow cells are likely precursors of erythroid and myeloid lineages (Figure 1e and f) and cells with terminally dierentiated myeloid features of multilobed nuclei had undetectable c-myb expression. c-Myb expression in adult bone marrow cells is highly restricted and occurs in a surprisingly small percentage of cells.
Developing trachea and proximal bronchial epithelial cells in the lung exhibit prominent expression at day 14, but the vast majority of epithelial cells in the more terminal bronchiolar structures exhibit no c-myb expression ( Figure 2a ). The same restricted proximal expression is also observed at E16 ( Figure 2b ) and postnatal day 9 ( Figure 2c ), with abrupt cessation of cmyb expression occurring at the transition from proximal conducting bronchiole to the more distal respiratory bronchiole (Figure 2c ). In the more proximal bronchial structures at post-natal day 9, strong c-myb expression was evident in a subset of epithelial cells (Figure 2e ). In contrast, by 2 months of age, c-myb expression is entirely absent in bronchial epithelial cells, and only slightly detectable in the tracheal epithelium (Figure 2d ).
In the gastrointestinal tract, c-myb was strongly expressed in immature pre-crypt epithelial cells of the small intestine on E14 (Figure 3b ), but was not evident at day 11.5 in the foregut (Figure 3a) . At day 14, the intestine resembles a simple tube with immature previllous structures. c-Myb expression was prominent in the basal epithelial cells between the developing villous structures. By day 16 (Figure 3d ), when the villi are clearly formed and highly extended, strong c-myb expression was completely restricted to the crypts, and absent from the villi. In the adult small bowel, an identical picture is maintained (Figure 3e ), with strong expression occurring throughout the crypt, extending up to the base of the villus. The immature ( Figure 3f ) and adult colon ( Figure 3g ) were also examined and found to have prominent c-myb expression con®ned to crypt epithelial cells. c-Myb is also expressed more proximally in the gastrointestinal tract, speci®cally in the esophageal forestomach (not shown) and diusely at a much lower level in gastric mucosal epithelial cells (not shown). Thus, expression of c-myb in the gastrointestinal tract was much more generalized, from early in development through the adult stages, and in proximal and distal bowel, than has been previously observed by Northern analyses in normal and neoplastic colonic mucosa (Torelli et al., 1987) or by immunohistochemistry in adult colonic crypts (Rosenthal et al., 1996) .
Strong c-Myb expression occurred in the bulb region of hair follicles at the midanagen stage within matrix cells that extend up into the lower third of the follicular matrix (Figure 4a ). Expression occurred in basal cells of the bulb (Figure 4b ), which are the least dierentiated, as well as in postmitotic cells beginning to dierentiate further up in the hair follicle, but not in the terminally dierentiated keratin-producing cells that are higher up in the follicle. Examination of follicles at early anagen revealed no detectable c-myb expression (Figure 4c ). Follicular cells at this stage are undergoing DNA replication as judged by PCNA staining (data not shown), and thymidine incorporation (Wilson et al., 1994) , but have not formed mature follicular structures. Telogen (rest) or catagen (regression) stage hair follicles also did not exhibit c-Myb expression (data not shown). c-Myb expression was observed in the bulb region of whisker vibrassae (Figure 4d ), similar to mid-anagen stage hair follicles. Thus, c-myb expression in hair follicles exhibits strong restriction to matrix cells during mid-anagen. Matrix cells at this stage are just basal to high-level keratin expression, and suggests that c-myb expression can serve as a molecular marker for cells that are undergoing a commitment to dierentiation program that gives rise to the hair follicle inner root sheath. A previous detection of c-Myb expression in hair follicles by RT ± PCR techniques (Seiberg et al., 1995) was not able to distinguish variations according to hair follicle growth cycle or to speci®c cell types and growth stages.
Teeth develop from the interaction of topologically similar epithelial and mesenchymal cell layers as in hair follicles and we sought to ascertain whether c-myb expression might also occur in this structure. Strong cmyb expression was evident within developing tooth buds of an E14 embryo (Figure 4e) . Expression of cmyb was localized to the dental papilla, a mesenchymal cell compartment, but was not expressed in the ectodermally derived dental lamina (Figure 4f) .
Strong c-myb expression also occurred in the developing thyroid primordium. The thyroid diverticulum originates as an outpouching of embryonic foregut near the base of the tongue which then migrates caudally to its ultimate location anterior to the trachea. At E12, the outpouching has undergone a condensation to form the thyroid primordium and exhibits extremely high c-myb expression (Figure 4g ). In contrast, there was no c-myb expression in the de®nitive thyroid gland present at day 16 (data not shown). This suggests an essentially identical phenomenon in which the loss of c-myb expression is associated with the initiation of maturation by the early thyroid rudiment.
Finally, we have also detected c-myb in several additional tissues at days 14 and 16.5 that include the subcapsular region of the kidney, regional epithelium of the inner ear, regional epithelium of the oropharynx, developing spleen, and the central nervous system, especially in the olfactory epithelium. Further studies will be necessary to determine the temporal patterns of its expression and potential function in these compartments.
Our observations support the general hypothesis that c-Myb functions in diverse lineages as both a transcriptional activator and, in multiple compartments, as a potential suppressor of terminal differentiation. Hematopoietic model systems have shown that (1) striking down-regulation of c-Myb expression is required for cell cycle exit and terminal differentiation (Kowenz-Leutz et al., 1997; Thompson et al., 1986) (Bellon et al., 1997; Homan et al., 1991) ; (2) insertional activation of the mouse c-myb gene can lead to myeloid leukemias (Nason and Wol, 1993; Wol et al., 1991) ; and (3) continuous expression of c-Myb in multipotential hematopoietic cells inhibits maturation (Selvakumaran et al., 1992) . Our observations point to an interpretation of the severe anemia of the c-Myb knockout (Mucenski et al., 1991) as representing a failure to maintain the immature status of developing hematopoietic cells. In addition, the disordered thymocyte dierentiation generated by a dominantnegative myb transgene (Badiani et al., 1994) may be indicating the importance of both c-Myb expression and its downregulation for successful intrathymic T-cell maturation. As a transcriptional regulator, c-Myb's ability to act positively upon cis-regulatory targets, for example within the context of complex regulatory regions (Ess et al., 1995; Aronow et al., 1995; Hernandez and Krangel, 1994) , has been implied to occur by its interaction with a variety of transcription factors including PEBP2 (Britos-Bray and Friedman, 1997), CBP (Dai et al., 1996) , ETS (McCracken et al., 1994; Shapiro, 1995) , NF-M (Ness et al., 1993) , ZEB (Postigo et al., 1997) , and heat shock factor-3 (KaneiIshii et al., 1997). However, the general model of cMyb activating select target genes via diverse interactions with cell-type speci®c factors does not appear to explain the observations in the present study.
Our hypothesis that c-Myb has a critical role as a suppressor of dierentiation is consistent with its expression pattern in potentially all of its sites of expression. In the developing lung, c-myb expression is restricted to proximal airways, absent from the more terminal structures, and down-regulated as the proximal airway epithelial cells undergo post-natal maturation when the upregulation of CC10 occurs (Bellusci et c-myb as an anti-differentiator in diverse cell types KC Ess et al al., 1996; Wert et al., 1993) . There is active proliferation in the earlier stages, as demonstrated by BrdU uptake (Bellusci et al., 1997) , but there is much less proximal epithelial proliferation at the stage at which c-myb expression continues. Thus, c-Myb downregulation in the developing lung correlates less with c-myb as an anti-differentiator in diverse cell types KC Ess et al Figure 4 c-myb expression in hair follicles, toothbuds and thyroid primordium. (a) Hair follicles in Mid-Anagen. c-myb is strongly expressed in a band of cells beginning at the follicular papilla and extending up into the lower third of the hair follicle. Hair cycle synchronization was initiated by clipping the dorsal hairs. At various times following shaving, mice were sacri®ced and skin samples collected for in situ hybridization. Stages of hair growth (telogen, early anagen, and anagen) were con®rmed by hair follicle histology (Stenn et al., 1994) . Con®rmation that these hair follicles are in anagen comes from the elongated appearance of the follicle and their distance from the epidermis. Within the developing oral cavity, c-myb expression is seen in the lower half of the dental papilla, the mesenchymal component of tooth buds. Expression is not seen in more dierentiated papilla cells or the overlying dental lamina (dl). Final magni®cation 1006. (f) Incisor Tooth Bud, Embryonic day 14, bright ®eld. Details of interacting cell types can be better appreciated with bright ®eld illumination. Note the columnar epithelium outlining the capped shape of the dental lamina (dl) over the dental papilla (dp). decreased proximal airway epithelial cell proliferation and more with the upregulation of terminal differentiation and CC10 expression. Similarly, the sharp transition zone of c-myb expression from conducting to respiratory bronchioles as shown in Figure 3c , suggests that the conducting bronchioles are prevented from undergoing terminal dierentiation. Previous studies have demonstrated c-myb expression in colon-derived human tumor cells (Torelli et al., 1987) and in crypt cells of mouse colon during both developmental and adult stages by immunohistochemistry (Rosenthal et al., 1996) . Using mRNA in situ analysis, we have expanded on these results to the entire gastrointestinal tract. We observe that from the earliest developmental stage at which villus-crypt formation is discernible, strong c-myb expression is restricted to epithelial cells in the crypt. This pattern is maintained from duodenum to colon. A notable point of our studies is that c-myb expression is abruptly lost at the neck of the crypt. This is in contrast to numerous studies demonstrating mitotic activity con®ned to a narrow band of cells near the base of the crypt (Goodlad et al., 1992; McDermott and Roudnew, 1976; Rosenthal et al., 1996) . The maturation of intestinal cells follows a highly proscribed course; proliferating stem cells in the lower crypt region continuously give rise to post-mitotic cells that migrate up the crypt, past the neck, and up the villous. No expression of terminal dierentiation villous epithelial markers such as sucrase/isomaltase (Chandrasena et al., 1992; Tung et al., 1997) , fatty acid binding protein (Cohn et al., 1992; Rottman and Gordon, 1993) , and adenosine deaminase (Witte et al., 1991) occurs until the cells cross the neck of the crypt. This is exactly the stage at which c-Myb expression is extinguished. An interesting consideration is the pleuripotentiality of crypt cells that allows them to dierentiate into enterocytes, goblet, or neuroendocrine cells (Gordon and Hermiston, 1994) . Thus, c-myb expression in the gastrointestinal tract correlates with the suppression of enterocyte epithelial cell terminal dierentiation, but not mitotic activity.
In cycling hair follicles, strong expression of c-myb in the matrix cells of mid-anagen hair follicles was similar to its expression in the other tissues undergoing developmental dierentiation. c-Myb was not expressed in catagen or telogen stage hair follicles. Hair follicles have been previously reported to express c-myb through RT ± PCR analyses of RNA from shaved mouse skin (Seiberg et al., 1995) , but the stage or cell type speci®city was unable to be addressed nor the potential contribution be discerned of c-myb expression by activated T cells or melanocytes (Gewirtz et al., 1989; Hijiya et al., 1994) . During anagen, we hypothesize that c-Myb could be serving to both suppress the terminal dierentiation of inner and outer root sheath cells derived from the follicular matrix cells (Zhou et al., 1995) , and regulate speci®c gene expression in the immature matrix cells. Interestingly, c-myb expression also occurs in feather buds, the avian homolog of hair (Desbiens et al., 1991) in zones of proliferation and early dierentiation.
The development of teeth is similar to hair follicles with complex epithelial mesenchymal interactions leading to the formation of a papilla and follicle that is overlayed by dierentiated epithelium (MacKenzie et al., 1992; van Genderen et al., 1994) . Our results demonstrate that c-Myb is present in the base of the papilla, which contains the least dierentiated cells, and is absent from the upper portion which are dierentiating into sub-odontoblasts and odontoblasts (Kollar, 1983) . Thus, the similarity of hair and tooth structural development is paralleled by the similarity of c-Myb expression within non-terminally dierentiated cells that undergoing lineage commitment.
The early thyroid primordium exhibited intense cmyb expression, but the de®nitive thyroid at day 16 exhibited no expression (data not shown). Interestingly, thyroglobulin, an important indicator of terminal dierentiation by follicular thyroid epithelium is not expressed at the mRNA level at day 13.5, but is at day 15 (Zannini et al., 1997) . This observation prompted the authors to postulate that the transcription factor TTF-2, which turns o between day 13.5 and 15, may repress the expression of terminal dierentiation genes. c-Myb may be also functioning in the same repression pathway, perhaps in collaboration with TTF-2. Other transcription factors expressed in both of these organs include TTF-1 and HNF-3 (Bohinski et al., 1994; Lazzaro et al., 1991) . It is also interesting to note that thyroid and lung develop as foregut outpouchings, suggesting that c-Myb may have a conserved function for both in repressing their terminal dierentiation and promoting their speci®c transcriptional programs.
There may be more functional similarity between the Myb family members (a-Myb, b-Myb and c-Myb) than previously realized. They share highly similar DNA binding and transactivation domains (Lam et al., 1992; Mizuguchi et al., 1990; Nakagoshi et al., 1993; Oh and Reddy, 1997; Tashiro et al., 1995) and are expressed by proliferating and non-terminally dierentiated lineages. There are both distinct and overlapping sites of expression. A-myb knockout mice have defects in late stage spermatogenesis and mammary gland development (Toscani et al., 1997; Trauth et al., 1994) . B-myb, expressed widely during embryogenesis (Sitzmann et al., 1996) and present in earlier stages of testes development, is also strongly down-regulated upon terminal dierentiation (Latham et al., 1996) . Thus, Myb proteins may have roles as both transcriptional activators and antagonists of terminal dierentiation.
This model of c-Myb acting as a suppressor of terminal dierentiation also provides a rationale for previously demonstrated participation of c-Myb in malignancies of several dierent leukemia types such as myeloid, erythroid, and lymphoid and predicts in the simple case that the dierentiated cells arising from these tumors would lack c-myb expression and fail to re-enter cycle. A variety of non-hematopoietic malignancies such as colon adenocarcinoma (Thompson et al., 1997) , small cell lung carcinoma (Bepler et al., 1989; Kiefer et al., 1987) , ovarian (Barletta et al., 1992) and pancreatic adenocarcinoma (Wallrapp et al., 1997) have all been reported to express signi®cant levels of cMyb. It is possible that the mis-expression of c-Myb or other Myb proteins in non-hematopoietic lineages may contribute to their malignant transformation, in part by blocking gene expression that is critical for terminal dierentiation.
